Filing Date | 
					T Date | 
					Ticker | 
										Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/23 16:02  | 2/16/23  | ACON | Health | Health | Medical Laboratories | Thramann Jeffrey John | CO | DO | Exec CB | P | 1 | 1,000.0 | 0 | 0 | New | 0 | D | ||||||||||||||
12/29/22 19:57  | 12/28/22  | ACON | Health | Health | Medical Laboratories | Ness Brent | CO | DO | CEO | P.m | 10 | 0.5280 | 0 | 19 | 999% | 20 | D | ||||||||||||||
12/29/22 18:27  | 12/29/22  | ACON | Health | Health | Medical Laboratories | Lorbiecki John Paul | CO | O | CFO | P | 10 | 0.4463 | 0 | 22 | 22 | D | |||||||||||||||
4/25/22 17:28  | 4/22/22  | ACON | Health | Health | Medical Laboratories | Bond Ryan | CA | O | Chief St | P.d | 56 | 2.80 | 0 | 20 | New | 20 | D | ||||||||||||||
4/25/22 17:27  | 4/21/22  | ACON | Health | Health | Medical Laboratories | Wesemann William | CA | D | P.d | 48 | 4.35 | 0 | 11 | 26 | 53 | D | |||||||||||||||
4/25/22 17:26  | 4/21/22  | ACON | Health | Health | Medical Laboratories | Ness Brent | CA | DO | CEO | P.d | 4 | 4.35 | 0 | 1 | New | 1 | D | ||||||||||||||
4/25/22 17:26  | 4/21/22  | ACON | Health | Health | Medical Laboratories | Neal David K | CA | D | P.d | 150 | 4.35 | 0 | 34 | New | 34 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |